2013
DOI: 10.1111/anae.12106
|View full text |Cite
|
Sign up to set email alerts
|

Sugammadex, rocuronium and mast cell numbers in the rat liver

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…For this reason, it has been reported that it causes histopathological findings such as skeletal muscle myopathy, vacuolization, pyknotic nuclei clumps, and thus causes disorders such as weakening of muscle fibers and hypertrophy (14). Since sugammadex is excreted from the kidneys and is not metabolized in the liver (15), there are a limited number of studies including its effect on liver morphology and enzymes (16). Clarke et al (17) reported that a cutaneous anaphylaxis effect in patients sensitive to rocuronium was alleviated with sugammadex after two minutes.…”
Section: Introductionmentioning
confidence: 99%
“…For this reason, it has been reported that it causes histopathological findings such as skeletal muscle myopathy, vacuolization, pyknotic nuclei clumps, and thus causes disorders such as weakening of muscle fibers and hypertrophy (14). Since sugammadex is excreted from the kidneys and is not metabolized in the liver (15), there are a limited number of studies including its effect on liver morphology and enzymes (16). Clarke et al (17) reported that a cutaneous anaphylaxis effect in patients sensitive to rocuronium was alleviated with sugammadex after two minutes.…”
Section: Introductionmentioning
confidence: 99%
“…In‐vitro and in‐vivo human models of anaphylaxis have not been able to demonstrate immunologically mediated attenuation of established anaphylaxis . We have raised theoretical objections about the plausibility of any such immunologically mediated benefits . For both ethical and practical reasons, a controlled clinical trial investigating this use of sugammadex in humans is unlikely.…”
Section: Introductionmentioning
confidence: 99%